Association of obstructive sleep apnoea with cardiovascular events in women and men with acute coronary syndrome.

Authors:
Wang X; Fan J; Guo R; Hao W; Gong W and 9 more

Journal:
Eur Respir J

Publication Year: 2023

DOI:
10.1183/13993003.01110-2022

PMCID:
PMC9881227

PMID:
36104289

Journal Information

Full Title: Eur Respir J

Abbreviation: Eur Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: Changsheng Ma reports honoraria from Bristol-Myers Squibb (BMS), Pfizer, Johnson & Johnson, Boehringer Ingelheim (BI), Bayer and AstraZeneca for giving lectures. Shaoping Nie reports research grants (paid to institution) from Boston Scientific, Abbott, Jiangsu Hengrui Pharmaceuticals, China Resources Sanjiu Medical & Pharmaceuticals and East China Pharmaceuticals. Virend K. Somers has served as a consultant for Respicardia, Bayer, Lilly, Resmed and Jazz Pharmaceuticals, and serves on the scientific advisory board for Sleep Number. The rest of the authors have no relevant relationships to disclose."

Evidence found in paper:

"Support statement: This study was funded by grants from Beijing Nova Program (Z201100006820087), Natural Science Foundation of Beijing, China (7222046), National Natural Science Foundation of China (81870322, 81900504), National Key R&D Program of China (2020YFC2004800), and Interdisciplinary Cooperation Project of Beijing Nova Program (Z211100002121165). Funding information for this article has been deposited with the Crossref Funder Registry."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025